These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 18644422)
41. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders. Barnett R; Maruff P; Vance A Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793 [TBL] [Abstract][Full Text] [Related]
42. Relationship of attention-deficit-hyperactivity disorder symptoms, depressive/anxiety symptoms, and life quality in young men. Chao CY; Gau SS; Mao WC; Shyu JF; Chen YC; Yeh CB Psychiatry Clin Neurosci; 2008 Aug; 62(4):421-6. PubMed ID: 18778439 [TBL] [Abstract][Full Text] [Related]
43. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy. Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014 [TBL] [Abstract][Full Text] [Related]
44. Effect of the treatment of brucellosis on leukocyte superoxide dismutase activity and plasma nitric oxide level. Karabulut AB; Sonmez E; Bayindir Y Ann Clin Biochem; 2005 Mar; 42(Pt 2):130-2. PubMed ID: 15829122 [TBL] [Abstract][Full Text] [Related]
45. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile]. Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827 [TBL] [Abstract][Full Text] [Related]
46. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility. Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial. Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227 [TBL] [Abstract][Full Text] [Related]
49. [Attention deficit hyperactivity syndrome and the capacity to practice sports]. Pascual-Castroviejo I Rev Neurol; 2004 Jun 1-15; 38(11):1001-5. PubMed ID: 15202073 [TBL] [Abstract][Full Text] [Related]
50. Sensitivity and specificity of long wave infrared imaging for attention-deficit/hyperactivity disorder. Coben R; Myers TE J Atten Disord; 2009 Jul; 13(1):56-65. PubMed ID: 19429882 [TBL] [Abstract][Full Text] [Related]
51. Determinants of quality of life in children with Gilles de la Tourette syndrome. Bernard BA; Stebbins GT; Siegel S; Schultz TM; Hays C; Morrissey MJ; Leurgans S; Goetz CG Mov Disord; 2009 May; 24(7):1070-3. PubMed ID: 19306279 [TBL] [Abstract][Full Text] [Related]
52. Differentiation between attention-deficit/hyperactivity disorder and pervasive developmental disorders with hyperactivity on objective activity levels using actigraphs. Tsujii N; Okada A; Kaku R; Kuriki N; Hanada K; Shirakawa O Psychiatry Clin Neurosci; 2009 Jun; 63(3):336-43. PubMed ID: 19566765 [TBL] [Abstract][Full Text] [Related]
53. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364 [TBL] [Abstract][Full Text] [Related]
54. Serum nerve growth factor (NGF) levels in children with attention deficit/hyperactivity disorder (ADHD). Guney E; Ceylan MF; Kara M; Tekin N; Goker Z; Senses Dinc G; Ozturk O; Eker S; Kizilgun M Neurosci Lett; 2014 Feb; 560():107-11. PubMed ID: 24361544 [TBL] [Abstract][Full Text] [Related]
55. [Correlation between ABO blood type gene and attention-deficit hyperactivity disorder in children]. Guo XS; Jiao BQ; Xu T Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):371-3. PubMed ID: 19470260 [TBL] [Abstract][Full Text] [Related]
56. Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: symptom or syndrome? Sinzig J; Walter D; Doepfner M J Atten Disord; 2009 Sep; 13(2):117-26. PubMed ID: 19380514 [TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077 [TBL] [Abstract][Full Text] [Related]
58. Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder. Pringsheim T; Sandor P; Lang A; Shah P; O'Connor P J Dev Behav Pediatr; 2009 Apr; 30(2):115-21. PubMed ID: 19322105 [TBL] [Abstract][Full Text] [Related]
59. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder. Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704 [TBL] [Abstract][Full Text] [Related]
60. An Internet version of the Diagnostic Interview Schedule for Children (DISC-IV): correspondence of the ADHD section with the paper-and-pencil version. Steenhuis MP; Serra M; Minderaa RB; Hartman CA Psychol Assess; 2009 Jun; 21(2):231-4. PubMed ID: 19485678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]